Max Hodak — Restoring Sight, Growing Neurons on Silicon, and Expanding Human Intelligence How a silicon chip is giving blind patients their sight back — and what comes next for the human brain.

Our CEO Max Hodak joined Juan Benet for a conversation about BCI breakthroughs at Science and how they will benefit patients.

Biohybrid BCIs will redefine how we interface with the brain.

The future won't just restore function — it'll expand it.

Full conversation with @maxhodak.bsky.social on the Juan Benet Podcast >>> bit.ly/4siB7Qp

PRIMA is a retinal implant from @science.xyz that's already restoring real vision.

This is how @maxhodak.bsky.social, founder and CEO of Science, is working to improve lives in meaningful ways.

Full conversation on the Juan Benet Podcast >>> bit.ly/4siB7Qp

Neo-cypherpunk spirit is activated through ecosystem: @juanbenet.bsky.social x @protocollabs.bsky.social joins our Berlin Summit.

Juan is the inventor of the @ipfs.tech & @filecoin.io. He makes pro-cypherpunk future practical via events like cypherpunk.camp

14 June: s26ber.web3privacy.info

Max Hodak — Restoring Sight, Growing Neurons on Silicon, and Expanding Human Intelligence YouTube video by Juan Benet Podcast

Excited to launch a new podcast on the future of neurotech, computing, intelligence, and more.

First guest: @maxhodak.bsky.social founder & CEO of @science.xyz building PRIMA, a retinal prosthetic restoring meaningful vision for patients with AMD.

www.youtube.com/watch?v=24CM...

Privy – Careers We believe that delightful products should empower users to maintain control over their data and assets online. That starts with better developer tooling.

2/ In 2026, Privy is focused on abstracting onchain complexity for developers and distributing via Stripe’s infrastructure.

They’re hiring, learn more. 👇

PL network team @privyio.bsky.social had a breakout 2025, scaling from 30M to 120M accounts, raising funding, and joining Stripe. Expanding from crypto-native apps to mainstream fintech, Privy is partnering with teams like Klarna to make onchain tools easier to use at global scale.

7/ This is the proposed roadmap for that coordination: doi.org/10.5281/zeno...

6/ Neurotech is entering a platform era. The devices are no longer static, they are adaptive, software-defined systems. Our regulatory and reimbursement systems need to catch up.

The next decade won’t be won by individual companies. It will be won by an ecosystem that moves fast together.

5/ This roadmap proposes a different approach: Not company-by-company progress, but coordinated, ecosystem-level infrastructure.

1. Close the FDA–CMS gap (<12 months)
2. Build shared CPT code frameworks
3. Create an “orphan implant” backstop
4. Align policy, capital, and clinical incentives

4/ This commercial valley of death delays:
-Patient access
-Company survival
-Capital formation
-Field-wide progress

If we fix time-to-revenue, we can unlock:
-Institutional capital at scale
-Faster clinical adoption
-The path to consumer neurotech

Clinical revenue is the acceleration layer.

3/ The question isn’t if neurotech will change the future of human health, it’s how quickly.

So far, the biggest constraint isn’t FDA approval, it’s what comes after: there’s a multi-year gap between “safe & effective” (FDA) and “paid for” (CMS).

2/ PL Neuro is sharing a roadmap series focused on answering the question: where does coordination compress timelines the most?

The first roadmap describes how the neurotech field can get to $100B+ — and faster.

1/ Neurotechnology is bottlenecked by systems, not science. Cochlear implants, deep brain stimulation, and neurostimulators have restored function for hundreds of thousands of patients and have collectively generated billions in annual reimbursements.

Homepage — PL Neuro

7/ If you’re building, researching, investing in, or shaping neurotechnology policy, please share your feedback.

Overview and roadmap one at: plneuro.xyz 👇

6/ Taken together, these roadmaps make one argument: the arrival of neurotechnology is inevitable. But the timeline is not and timelines matter for patients, for science, for society.

This series is a starting point for deeper collaboration across the field.

5/ This roadmap series is a strategic briefing focused on one question:

Where does coordination compress timelines the most?

Four core bottlenecks:

1. Path to clinical revenue
2. Transition to consumer
3. Public narrative & trust
4. Capital formation

4/ What’s slowing the field now?

- regulatory lag
- reimbursement gaps
- capital constraints
- public trust

In other words: structural friction.

Today, each company is forced to navigate these barriers alone. Neurotech needs shared infrastructure: a Neurotech Commons.

3/ PL Neuro is sharing a roadmap series for that future.

Safe, high-fidelity neural interfaces have been substantially de-risked. So the bottleneck is shifting from science to systems.

2/ It’s no longer speculative. Now, the question is how fast can it translate into real products, real companies, and real patient impact.

1/ Neurotechnology is one of the defining opportunities of this century. We’re already seeing the potential to restore function, treat disease, and eventually expand human capability.

Bluesky's 2025 $100M Series B Lays Foundation for Open Social Web - Bluesky In April 2025, Bluesky raised $100 million in Series B funding led by Bain Capital Crypto. Since our Series A, we've grown from 13 million to over 43 million global users.

@bsky.app's Series B marks a new phase for open social infrastructure.

Not just an “X alternative”—it’s building toward portable identity, user-controlled algorithms, and a modular ecosystem.

43M+ users. The shift to user-owned networks is underway.

AtmosphereConf Sponsor: Protocol Labs - ATmosphereConf News Protocol Labs is a sponsor of AtmosphereConf, supporting lunch for the Founders & Funders Workshop

We are welcoming @protocollabs.bsky.social as our final #AtmosphereConf sponsor to be announced

Protocol Labs is the original creator of IPFS and continues to grow an innovation network around driving breakthroughs in computing.

New case study is out! Cypherpunk Retreat - 3 days of close collaboration between 100 great freedom shapers from
@bsky.app, @torproject.org, @freedom.press, @germnetwork.com...

facilitated by @web3privacy.info & @protocollabs.bsky.social

Together: paragraph.com/@web3privacy...

PL Neuro team Synchron is taking a minimally invasive, endovascular BCI approach, with miniaturized electronics in hermetically encapsulated packages. A distinct engineering path with different constraints than systems requiring open brain surgery.

Meet the Head of PL Neuro, @seanescola.bsky.social.

In his new paper, he introduces the idea of “cognitive dark matter."

A thoughtful framing of one of the biggest open questions in neuroscience. 👇

2/ Using a minimally invasive, stent-like procedure, the technology is designed to let neural signals control digital devices, addressing physical limitations without opening the skull.

Synchron's Stentrode is a self-expanding sensor array delivered via catheter through the jugular vein to the brain, enabling brain-computer interface functionality without open brain surgery.

Big news! @protocollabs.bsky.social activated membership x Web3privacy now for 2026.

Members are our trusted companions. Instead of one-time collaboration for events or projects, we strive for ongoing partnerships that create lasting impact.

2/ Learn more. 👇